Tecan Ag Hombr N Akt (TCHBF) 143.2100 $TCHBF
Tecan announces Capital Markets Day
Globe Newswire - Thu Jun 09, 4:15AM CDT
Tecan Group AG / Tecan announces Capital Markets Day . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Annual General Meeting 2016: Tecan shareholders endorse all motions proposed by the Board of Directors
Globe Newswire - Wed Apr 13, 11:00AM CDT
Tecan Group AG / Annual General Meeting 2016: Tecan shareholders endorse all motions proposed by the Board of Directors . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
U.S. Molecular Diagnostics Market Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Becton Dickinson, Biotest, Tecan Group - Research and Markets
BusinessWire - Thu Mar 31, 1:15PM CDT
Research and Markets has announced the addition of the "2016-2020 U.S. Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic" report to their offering.
Tecan publishes 2015 Annual Report and notice of its Annual General Meeting
Globe Newswire - Wed Mar 23, 1:16AM CDT
Tecan Group AG / Tecan publishes 2015 Annual Report and notice of its Annual General Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global Tissue Banking Market Report 2014-2020 - Analysis, Technologies & Forecasts - Key Vendors: Tecan Group, Cureline, Tissue Banks International - Research and Markets
BusinessWire - Wed Mar 16, 10:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kjxpw9/tissue_banking) has announced the addition of the "Tissue Banking Market Forecast and Analysis (2014 - 2020): By tissue (Bone, Skin, Heart Valves and others), By Equipment (Cryopreservation systems, Thawing equipment and others), By Application (Clinical, Cosmetic, Research) & By Geography" report to their offering.
Tecan with high growth in sales and net profit in fiscal year 2015
Globe Newswire - Tue Mar 15, 12:01AM CDT
Tecan Group AG / Tecan with high growth in sales and net profit in fiscal year 2015 . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
UK Molecular Diagnostic Analyzers & Reagents Market Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Becton Dickinson, Shimadzu, Tecan Group - Research and Markets
BusinessWire - Fri Mar 11, 12:55PM CST
Research and Markets (http://www.researchandmarkets.com/research/cwcb4p/20162020_uk) has announced the addition of the "2016-2020 UK Molecular Diagnostic Analyzers and Reagents Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing" report to their offering.
Tecan schedules Analyst and Media Conference on March 15 to discuss Full-Year 2015 Financial Results
Globe Newswire - Tue Mar 08, 12:30AM CST
Tecan Group AG / Tecan schedules Analyst and Media Conference on March 15 to discuss Full-Year 2015 Financial Results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
33-Country Molecular Diagnostics Market Report - Analysis, Technologies, Opportunities & Forecast 2016-2021 - Key Vendors: Abbott, Arca Biopharma
M2 - Fri Feb 05, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/krshdj/a_33country) has announced the addition of the "A 33-Country Survey of the Molecular Diagnostics Market" report to their offering. This new 33-country survey contains over 1,600 pages, 350 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Supplier sales and market shares in major countries - Five-year test volume and sales forecasts - Strategic profiles of market players and start-up firms developing innovative technologies and products - Emerging technologies - Review of molecular diagnostic analyzers - Specific product and business opportunities for instrument and consumable suppliers The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kr..._33country
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Canada Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/psx4dl/2016_canada) has announced the addition of the "2016 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/ps...016_canada
SQNM: 1.01 (-0.12), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Ireland Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6zczz/2016_ireland) has announced the addition of the "2016 Ireland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/k6...16_ireland
A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Wed Feb 03, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/w25rjt/2016_u_s) has announced the addition of the "2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Grifols - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/w25rjt/2016_u_s
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08)
2016 U.S. Nucleic Acid Testing/NAT Market - Sales and Market Shares of Major Suppliers
M2 - Tue Feb 02, 10:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t27jjr/2016_u_s_nucleic) has announced the addition of the "2016 U.S. Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/t2..._s_nucleic
MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08)
2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
M2 - Tue Feb 02, 10:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/3m8nhx/2016_u_s_genetic) has announced the addition of the "2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others Product/Technology Review - Comparison of the major molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostict echnologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Illumina - Kreatech/Leica - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/3m..._s_genetic
LIFE: 2.65 (-0.21), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08)
Cell Analysis Market Forecast to 2020 - Expected to Reach $26 Billion, Growing at CAGR of 6.56%
M2 - Mon Jan 25, 3:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxg28x/cell_analysis) has announced the addition of the "Cell Analysis Market by Product, & Consumables, by Process, & by End User - Forecast to 2020" report to their offering. The global cell analysis market is expected to reach $26.0 billion by 2020 from $19.0 billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. The instruments segment is expected to register the highest growth rate in the cell analysis market, by product, during the forecast period. Its favorable growth is attributed to biological relevance for new drug discoveries, cancer research, and government funding & support for cell-based research. Furthermore, instruments are rapidly adopted by biotechnology and biopharmaceutical industries for performing cell analysis biotechnology products and biopharmaceuticals. This is another major reason for the growth of this market. Major factors contributing to growth of the cell analysis market include: - Rising incidence of chronic and infectious diseases - Growing healthcare industry and medical spending - Rising incidence of cancer - Introduction of technologically advanced products - Corporate and government funding for cell-based research. The relatively untapped markets of the Asia-Pacific region and the advent of microfluidics in cell analysis have opened an array of opportunities for the cell analysis market. However, reluctance amongst researchers to use advanced cell analysis techniques and high cost of instruments are expected to restrain the growth of this market. Companies Mentioned: - Agilent Technologies, Inc. - Becton, Dickinson and Company - Danaher Corporation - GE Healthcare - Merck KGAA - Olympus Corporation - Perkinelmer, Inc. - Promega Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Global Cell Analysis Market, By Product 7 Global Cell Analysis Market, By Process 8 Global Cell Analysis Market, By End User 9 Global Cell Analysis Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/mx...l_analysis
A: 42.28 (-1.84), DHR: 97.13 (-1.08)
Global Molecular Diagnostics Market Report - Analysis, Technologies, Strategies & Forecasts 2016
M2 - Tue Jan 12, 3:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/2cw6kx/competing_in_the) has announced the addition of the "Competing in the 2016 Global Molecular Diagnostics Market" report to their offering. This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain, UK, and US - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers Worldwide Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment - Five-year test volume and sales projections by country Market Segmentation Analysis: - Sales and market shares of major suppliers of molecular diagnosticreagent kits and components - Five-year test volume and sales forecasts for major applications, including: Infectious Diseases, Forensic Testing, Cancer, Paternity Testing/HLA Typing, Genetic Diseases, Others - Five-year test volume and sales projections for over 30 NAT assays - A comprehensive analysis of the sequencing market, by country and laboratory segment, including: Industrial, Academic, Government, Commercial - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country Competitive Assessments: - Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D - Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application Contains 1398 pages and 194 tables Companies Mentioned Include: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/2c...ing_in_the
SQNM: 1.01 (-0.12), A: 42.28 (-1.84), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Tecan to present at J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Mon Jan 11, 1:30AM CST
Tecan Group AG / Tecan to present at J.P. Morgan Healthcare Conference . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
JPM: 57.14 (-2.46)
Global Nucleic Acid Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Tue Dec 29, 10:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/2gjbfn/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This unique seven-country report contains 1,398-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Contains 1398 pages and 194 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/2g...016_future
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Future Horizons & Growth Strategies in the UK Molecular Diagnostics Market: Shares, Forecasts, Intelligence & Opportunities 2016
M2 - Tue Dec 29, 10:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/kmpt6j/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the UK Molecular Diagnostics Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This new 1122-page report contains 53 tables, and presents a comprehensive analysis of the UK molecular diagnostics market, including:Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.Ten-year test volume and reagent sales forecasts for the following categories: - Infectious Diseases - Genetic Diseases - Cancer - Paternity Testing/HLA Typing - Forensic Testing Review of testing methodologies an instrumentation technologies.Feature comparison of automated and semiautomated analyzers.Sales and market shares of leading suppliers.Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Alternative market penetration strategies.Potential market entry barriers and risks.Business planning issues and concerns.Contains 1,122 pages and 53 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/km...016_future
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Global Molecular Diagnostic Product Suppliers Report 2016 - Sales & Market Shares by Test and Country
M2 - Tue Dec 29, 9:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/7g8r2r/2016_global) has announced the addition of the "2016 Global Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test and Country" report to their offering. This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/7g...016_global
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Tecan announces Capital Markets Day
Globe Newswire - Thu Jun 09, 4:15AM CDT
Tecan Group AG / Tecan announces Capital Markets Day . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Annual General Meeting 2016: Tecan shareholders endorse all motions proposed by the Board of Directors
Globe Newswire - Wed Apr 13, 11:00AM CDT
Tecan Group AG / Annual General Meeting 2016: Tecan shareholders endorse all motions proposed by the Board of Directors . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
U.S. Molecular Diagnostics Market Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Becton Dickinson, Biotest, Tecan Group - Research and Markets
BusinessWire - Thu Mar 31, 1:15PM CDT
Research and Markets has announced the addition of the "2016-2020 U.S. Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic" report to their offering.
Tecan publishes 2015 Annual Report and notice of its Annual General Meeting
Globe Newswire - Wed Mar 23, 1:16AM CDT
Tecan Group AG / Tecan publishes 2015 Annual Report and notice of its Annual General Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global Tissue Banking Market Report 2014-2020 - Analysis, Technologies & Forecasts - Key Vendors: Tecan Group, Cureline, Tissue Banks International - Research and Markets
BusinessWire - Wed Mar 16, 10:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kjxpw9/tissue_banking) has announced the addition of the "Tissue Banking Market Forecast and Analysis (2014 - 2020): By tissue (Bone, Skin, Heart Valves and others), By Equipment (Cryopreservation systems, Thawing equipment and others), By Application (Clinical, Cosmetic, Research) & By Geography" report to their offering.
Tecan with high growth in sales and net profit in fiscal year 2015
Globe Newswire - Tue Mar 15, 12:01AM CDT
Tecan Group AG / Tecan with high growth in sales and net profit in fiscal year 2015 . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
UK Molecular Diagnostic Analyzers & Reagents Market Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Becton Dickinson, Shimadzu, Tecan Group - Research and Markets
BusinessWire - Fri Mar 11, 12:55PM CST
Research and Markets (http://www.researchandmarkets.com/research/cwcb4p/20162020_uk) has announced the addition of the "2016-2020 UK Molecular Diagnostic Analyzers and Reagents Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing" report to their offering.
Tecan schedules Analyst and Media Conference on March 15 to discuss Full-Year 2015 Financial Results
Globe Newswire - Tue Mar 08, 12:30AM CST
Tecan Group AG / Tecan schedules Analyst and Media Conference on March 15 to discuss Full-Year 2015 Financial Results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
33-Country Molecular Diagnostics Market Report - Analysis, Technologies, Opportunities & Forecast 2016-2021 - Key Vendors: Abbott, Arca Biopharma
M2 - Fri Feb 05, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/krshdj/a_33country) has announced the addition of the "A 33-Country Survey of the Molecular Diagnostics Market" report to their offering. This new 33-country survey contains over 1,600 pages, 350 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Supplier sales and market shares in major countries - Five-year test volume and sales forecasts - Strategic profiles of market players and start-up firms developing innovative technologies and products - Emerging technologies - Review of molecular diagnostic analyzers - Specific product and business opportunities for instrument and consumable suppliers The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kr..._33country
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Canada Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/psx4dl/2016_canada) has announced the addition of the "2016 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/ps...016_canada
SQNM: 1.01 (-0.12), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Ireland Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6zczz/2016_ireland) has announced the addition of the "2016 Ireland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/k6...16_ireland
A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Wed Feb 03, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/w25rjt/2016_u_s) has announced the addition of the "2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Grifols - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/w25rjt/2016_u_s
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08)
2016 U.S. Nucleic Acid Testing/NAT Market - Sales and Market Shares of Major Suppliers
M2 - Tue Feb 02, 10:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t27jjr/2016_u_s_nucleic) has announced the addition of the "2016 U.S. Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/t2..._s_nucleic
MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08)
2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
M2 - Tue Feb 02, 10:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/3m8nhx/2016_u_s_genetic) has announced the addition of the "2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others Product/Technology Review - Comparison of the major molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostict echnologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Illumina - Kreatech/Leica - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/3m..._s_genetic
LIFE: 2.65 (-0.21), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08)
Cell Analysis Market Forecast to 2020 - Expected to Reach $26 Billion, Growing at CAGR of 6.56%
M2 - Mon Jan 25, 3:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxg28x/cell_analysis) has announced the addition of the "Cell Analysis Market by Product, & Consumables, by Process, & by End User - Forecast to 2020" report to their offering. The global cell analysis market is expected to reach $26.0 billion by 2020 from $19.0 billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. The instruments segment is expected to register the highest growth rate in the cell analysis market, by product, during the forecast period. Its favorable growth is attributed to biological relevance for new drug discoveries, cancer research, and government funding & support for cell-based research. Furthermore, instruments are rapidly adopted by biotechnology and biopharmaceutical industries for performing cell analysis biotechnology products and biopharmaceuticals. This is another major reason for the growth of this market. Major factors contributing to growth of the cell analysis market include: - Rising incidence of chronic and infectious diseases - Growing healthcare industry and medical spending - Rising incidence of cancer - Introduction of technologically advanced products - Corporate and government funding for cell-based research. The relatively untapped markets of the Asia-Pacific region and the advent of microfluidics in cell analysis have opened an array of opportunities for the cell analysis market. However, reluctance amongst researchers to use advanced cell analysis techniques and high cost of instruments are expected to restrain the growth of this market. Companies Mentioned: - Agilent Technologies, Inc. - Becton, Dickinson and Company - Danaher Corporation - GE Healthcare - Merck KGAA - Olympus Corporation - Perkinelmer, Inc. - Promega Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Global Cell Analysis Market, By Product 7 Global Cell Analysis Market, By Process 8 Global Cell Analysis Market, By End User 9 Global Cell Analysis Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/mx...l_analysis
A: 42.28 (-1.84), DHR: 97.13 (-1.08)
Global Molecular Diagnostics Market Report - Analysis, Technologies, Strategies & Forecasts 2016
M2 - Tue Jan 12, 3:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/2cw6kx/competing_in_the) has announced the addition of the "Competing in the 2016 Global Molecular Diagnostics Market" report to their offering. This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain, UK, and US - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers Worldwide Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment - Five-year test volume and sales projections by country Market Segmentation Analysis: - Sales and market shares of major suppliers of molecular diagnosticreagent kits and components - Five-year test volume and sales forecasts for major applications, including: Infectious Diseases, Forensic Testing, Cancer, Paternity Testing/HLA Typing, Genetic Diseases, Others - Five-year test volume and sales projections for over 30 NAT assays - A comprehensive analysis of the sequencing market, by country and laboratory segment, including: Industrial, Academic, Government, Commercial - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country Competitive Assessments: - Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D - Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application Contains 1398 pages and 194 tables Companies Mentioned Include: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/2c...ing_in_the
SQNM: 1.01 (-0.12), A: 42.28 (-1.84), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Tecan to present at J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Mon Jan 11, 1:30AM CST
Tecan Group AG / Tecan to present at J.P. Morgan Healthcare Conference . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
JPM: 57.14 (-2.46)
Global Nucleic Acid Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Tue Dec 29, 10:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/2gjbfn/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This unique seven-country report contains 1,398-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Contains 1398 pages and 194 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/2g...016_future
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Future Horizons & Growth Strategies in the UK Molecular Diagnostics Market: Shares, Forecasts, Intelligence & Opportunities 2016
M2 - Tue Dec 29, 10:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/kmpt6j/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the UK Molecular Diagnostics Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This new 1122-page report contains 53 tables, and presents a comprehensive analysis of the UK molecular diagnostics market, including:Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.Ten-year test volume and reagent sales forecasts for the following categories: - Infectious Diseases - Genetic Diseases - Cancer - Paternity Testing/HLA Typing - Forensic Testing Review of testing methodologies an instrumentation technologies.Feature comparison of automated and semiautomated analyzers.Sales and market shares of leading suppliers.Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Alternative market penetration strategies.Potential market entry barriers and risks.Business planning issues and concerns.Contains 1,122 pages and 53 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/km...016_future
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
Global Molecular Diagnostic Product Suppliers Report 2016 - Sales & Market Shares by Test and Country
M2 - Tue Dec 29, 9:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/7g8r2r/2016_global) has announced the addition of the "2016 Global Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test and Country" report to their offering. This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/7g...016_global
SQNM: 1.01 (-0.12), MYGN: 29.45 (-0.55), A: 42.28 (-1.84), CPHD: 28.28 (-0.79), DHR: 97.13 (-1.08), HOLX: 32.96 (-1.15)
